Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
The control of reactive oxygen species production by SHP-1 in oligodendrocytes.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells.
The epidemiology and pathophysiology of neurogenic bladder.
The impact of the human genome project on complex disease.
PERK Dependent Activation of JAK1 and STAT3 Contributes to ER Stress Induced Inflammation.
How type I interferons shape myeloid cell function in CNS autoimmunity.
Baló's Concentric Sclerosis in Multiple Sclerosis.
Identity of the elusive IgM Fc receptor (FcmuR) in humans.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Multiple sclerosis: Month of birth effect in MS-fact or artefact?
Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection.
Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
Cognitive impairment in Chinese neuromyelitis optica.
Moral Distress: Recognition, Diagnosis, and Treatment.
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI.
Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Comparison of MERGE and Axial T2-Weighted Fast Spin-Echo Sequences for Detection of Multiple Sclerosis Lesions in the Cervical Spinal Cord.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.
Pages
« first
‹ previous
…
284
285
286
287
288
289
290
291
292
…
next ›
last »